Clinical Trial Update: SPEARHEAD-3 Pediatric Study [Phase 1, Phase 2]

View source ↗

Summary

SPEARHEAD-3 is a pediatric study enrolling in Phase 1 and Phase 2 across multiple cancers, including synovial sarcoma, malignant peripheral nerve sheath tumor, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor
• Neuroblastoma
• Osteosarcoma
• Synovial Sarcoma

Snippet

Sponsor: USWM CT, LLC | Conditions: Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1, Phase 2 | Status: RECRUITING